PIMs is therefore a potential therapeutic target for the treatment of cancers in which it is induced; several PIM kinase inhibitors have been identified, including the pan-PIM inhibitors AZD1208, SC1776, LGH447 and TP3654, some of which are currently assessed in clinical trials [13]. Here, PIM1 is linked to cancer.